Document is current

Article History

First Online: 7 August 2025

Competing interests

: A.J.M. has served as a paid advisor/consultant for AstraZeneca, Edgewood Oncology, Guardant Health, Illumina, Myriad Genetics, Natera, Novartis, Reversing Early Recurrence and Science for America, and has been a non-remunerated advisor/consultant for SAGA Diagnostics, all outside the submitted work. S.A.W. has received honoraria as an advisor/consultant for AstraZeneca, Biovica, Eli Lilly, Foundation Medicine, Genentech, Gilead, Hologic, Novartis, Pfizer/Arvinas, Puma Biotechnology, Regor Therapeutics, Stemline/Menarini and Veracyte, and as an educational speaker for 2ndMD, Eli Lilly and Guardant Health; and their institution receives research support from Eli Lilly, Genentech, Nuvation Bio, Pfizer/Arvinas, Phoenix Molecular Designs, Puma Biotechnology, Regor Therapeutics, Sermonix and Stemline/Menarini.